News

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...
It pains me to think I won’t be able to fully see my grandchildren’s faces and fully experience the biggest moments of my ...
While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...
A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...
Medications taken for weight loss are starting to impact wedding planning — and perhaps nothing more than the dress fitting.
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...
Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...
Hims & Hers Health, Inc. teams up with Novo Nordisk to offer Wegovy at $599/month, slashing costs. Click for why this is a ...
Key Takeaways Hims & Hers Health shares surged Tuesday as the company announced a partnership with Danish drugmaker Novo ...
Federal law allows compounding pharmacies to make copies of name brand drugs while there’s a supply shortage. But there's a ...
The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...
The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...